BioPharm News

Sep 02, 2015
By BioPharm International Editors
The collaborative effort will be focused on fully humanized antibodies.
Sep 02, 2015
By BioPharm International Editors
The platform, developed by Vectron Biosolutions, will be used for BI’s in-house pipeline and for its outsourcing clients.
Sep 02, 2015
The investigational monoclonal antibody targets interleukin-17 and is in clinical trials for the treatment of plaque psoriasis.
Sep 01, 2015
By BioPharm International Editors
USP joins the Global Health Supply Chain Technical Assistance program to help secure the drug supply chain.
Aug 28, 2015
The drug was the first PCSK9 inhibitor approved in Europe and the second approved in the US.
Aug 28, 2015
By BioPharm International Editors
Growth is said to be driven by the deeper penetration of biosimilars in developed and emerging markets as a result of clearer regulatory pathways.
Aug 27, 2015
In a new draft guidance, FDA proposes the use of a nonproprietary name plus a four-letter suffix to identify all biologic products, both new and old.
Aug 27, 2015
By BioPharm International Editors
GSK announces plan to divest its rights in ofatumumab for auto-immune indications for up to $1 billion.
Aug 26, 2015
By BioPharm International Editors
The new company, Immatics US, will develop autologous and allogeneic adoptive cellular therapies for various types of tumors based on novel immunotherapy targets.
Aug 26, 2015
By BioPharm International Editors
Merus announced new investors and the sale of $80.5 million in shares to advance its immuno-oncology programs.